ABSTRACT
Our goal was to conduct a controlled study using an established timed-pregnant baboon
model to describe the maternal and fetal plasma glucose and insulin concentrations
during graded increases in maternal circulating glucose levels. Timed-pregnant baboons
were operated on during the second half of pregnancy, and after recovery from surgery,
maternal glucose infusions were started. To determine changes in plasma glucose and
insulin concentrations, maternal and fetal blood samples were obtained before glucose
infusion and at 30-minute intervals to include 30 minutes postinfusion. Maternal plasma
glucose concentrations ranged from 97 to 392 mg/dL and fetal plasma glucose concentrations
from 78 to 278 mg/dL. Maternal plasma insulin concentrations ranged from 123 to 1384
U/mL, and the fetal plasma insulin concentrations from 76 to 260 U/mL. Significant
correlations were noted between maternal plasma glucose and insulin concentrations
(N = 10; R
2, 80%; p < 0.001), as well as maternal and fetal plasma glucose concentrations (N = 10; R
2, 97%; p < 0.001). Maternal-to-fetal glucose gradient ranged from 16 to 34% (mean, 23%) and
did not correlate with maternal plasma glucose concentration. No correlation was found
between fetal plasma glucose and insulin concentration. Maternal-to-fetal insulin
gradient ranged from 31 to 87% (mean, 70.7%) and was significantly different from
the glucose gradient (p < 0.0001). Results from this study suggests that (1) there is a relatively steady
transplacental glucose transfer during the second half of pregnancy at maternal plasma
glucose concentrations ranging from 97 to 392 mg/dL; and (2) there is also a relative
incapacity of the fetal pancreas, compared with the maternal pancreas, to respond
to graded increases of hyperglycemia. Studies aimed at determining whether particular
thresholds of maternal hyperglycemia at different gestational ages can lead to transitory
hyperosmolar and polyuric fetal states could provide further insights into the mechanisms
leading to idiopathic polyhydramnios.
KEYWORDS
Diabetes in pregnancy - fetal surgery - fetal glucose homeostasis
REFERENCES
- 1
Edlund H.
Pancreatic organogenesis-developmental mechanisms and implications for therapy.
Nat Rev Genet.
2002;
3
524-532
- 2
Bell G I, Pictet R L, Rutter W J, Cordell B, Tischer E, Goodman H M.
Sequence of the human insulin gene.
Nature.
1980;
284
26-32
- 3
Adesanya T, Grillo I, Shima K.
Insulin content and enzyme histochemistry of the human foetal pancreatic islet.
J Endocrinol.
1966;
36
151-158
- 4
Espinosa de los Monteros A, Driscoll S G, Steinke J.
Insulin release from isolated human fetal pancreatic islets.
Science.
1970;
168
1111-1112
- 5
Milner R D, Hill D J.
Fetal growth control: the role of insulin and related peptides.
Clin Endocrinol (Oxf).
1984;
21
415-433
- 6
Sara V R, Hall K, Misaki M, Fryklund L, Christensen N, Wetterberg L.
Ontogenesis of somatomedin and insulin receptors in the human fetus.
J Clin Invest.
1983;
71
1084-1094
- 7
Pedersen J, Bojsen-Moller B, Poulsen H.
Blood sugar in newborn infants of diabetic mothers.
Acta Endocrinol (Copenh).
1954;
15
33-52
- 8
Bell A W, Kennaugh J M, Battaglia F C, Makowski E L, Meschia G.
Metabolic and circulatory studies of fetal lamb at midgestation.
Am J Physiol.
1986;
250
E538-E544
- 9
Nicolini U, Hubinont C, Santolaya J, Fisk N M, Coe A M, Rodeck C H.
Maternal-fetal glucose gradient in normal pregnancies and in pregnancies complicated
by alloimmunization and fetal growth retardation.
Am J Obstet Gynecol.
1989;
161
924-927
- 10
Nicolini U, Hubinont C, Santolaya J, Fisk N M, Rodeck C H.
Effects of fetal intravenous glucose challenge in normal and growth retarded fetuses.
Horm Metab Res.
1990;
22
426-430
- 11
Herring J M, Fortman J D, Anderson R J, Bennett B T.
Ultrasonic determination of fetal parameters in baboons (Papio anubis).
Lab Anim Sci.
1991;
41
602-605
- 12
Santolaya-Forgas J, Romero R, Mehendale R.
The effect of continuous morphine administration on maternal plasma oxytocin concentration
and uterine contractions after open fetal surgery.
J Matern Fetal Neonatal Med.
2006;
, In press
- 13
Susa J B, Neave C, Sehgal P, Singer D B, Zeller W P, Schwartz R.
Chronic hyperinsulinemia in the fetal rhesus monkey. Effects of physiologic hyperinsulinemia
on fetal growth and composition.
Diabetes.
1984;
33
656-660
- 14
De Prins F A, Hill D J, Fekete M et al..
Reduced plasma somatomedin activity and costal cartilage sulfate incorporation activity
during experimental growth retardation in the fetal rat.
Pediatr Res.
1984;
18
1100-1104
- 15
Hill D J, Milner R D.
Insulin as a growth factor.
Pediatr Res.
1985;
19
879-886
- 16 Henry J B. Clinical Diagnosis and Management by Laboratory Methods. 17th ed. Philadelphia;
WB Saunders 1984: 411
Joaquin Santolaya-ForgasM.D. Ph.D.
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, WSU/Hutzel
Women's Hospital
3990 John R Road, 7 Brush North, Detroit, MI, 48201